EPCAM and lung cancer: Thus, we also performed a functional study of CRISPR/Cas9-mediated lncCDH5-3:3 knockout (KO), and overexpression outcomes on the CDH1 and EPCAM expression, cell cycle, proliferation, and apoptosis in lung cancer cells.